Pharmaceutical industry

MPs call for more patient input to address UK’s medicines shortages problem

A report from the All-Party Parliamentary Group on Pharmacy has called for the creation of a national patient advisory panel on medicines shortages.…

Three-quarters of pharmacists say patient safety is at risk from medicine delays

Responding to Community Pharmacy England’s pharmacy pressures survey, 87% of pharmacy staff also reported daily problems arising from supply issues, up from 67% in 2022.…

‘Are people believing this information?’: research raises concerns over online drug marketing

Zita Zachariah, managing editor of the RPS journals, speaks with Jessica Mor, whose award-winning research has highlighted the need for updated regulation of social media drug marketing.…

GPhC highlights need to improve performance in five-year strategy

To meet its goals under its strategic plan for 2025–2030, the regulator said it must improve its fitness-to-practise processes, streamline investigations and ensure financial stability.…

MHRA publishes ‘world first’ decentralised manufacturing guidance

The guidance will inform the manufacture of medicines with a short shelf-life or highly personalised medicines at sites within or in close proximity to hospitals.…

Recognising adverse events and using the Yellow Card system

An overview of how to identify, manage and report adverse events.…

Yellow Card reporting in East London NHS Foundation Trust

The Yellow Card scheme is a system for reporting adverse drug reactions (ADRs) from medicines or adverse incidents with medical devices in the UK, ensuring that these products are safe for both healthcare professionals and patients1–3. Reporting these issues helps the MHRA to identify new sa…

Grasping new opportunities to work in partnership with the pharmaceutical industry

The development of a pharmacy-led maintenance and reliever therapy programme has shown success in Leeds, where there are high numbers of people with unmanaged asthma.…

MHRA urges women taking weight-loss drugs to use effective contraception

Guidance published by the medicines regulator has warned that patients trying to conceive should remain on contraception for a “wash-out” period after stopping GLP-1 receptor agonists.…

What difference will hub-and-spoke dispensing actually make?

This month, our health policy columnist mulls over the true impact of the roll-out of hub-and-spoke community pharmacy prescription filling between different organisations.…